Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | - | $ 4.45M | $ 4.88M | $ 995.76K | $ 1.46M |
Total Assets | - | $ 1.30B | $ 1.25B | $ 1.25B | $ 1.14B |
Total Debt | $ 0.00 | $ 837.43M | $ 804.32M | $ 824.96M | $ 744.23M |
Net Debt | $ 0.00 | $ 832.98M | $ 799.44M | $ 823.96M | $ 742.78M |
Total Liabilities | - | $ 992.30M | $ 954.96M | $ 971.40M | $ 875.40M |
Stockholders Equity | - | $ 312.56M | $ 294.22M | $ 277.35M | $ 268.87M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |